Gold vs US Dollar

Register for streaming realtime charts, analysis tools, and prices.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Akebia Therapeutics Inc (AKBA)
Akebia Therapeutics Inc (AKBA) Financials

AKBA Akebia Therapeutics Inc

1.8798

0.0898 (5.02%)

21 Dec 2024 - Closed

Delayed by 15 minutes

Statistics

Annual Quarterly

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Return on Assets (%)	-61.264	-23.151	-21.104	-31.64	-54.186	-48.362	-21.1	-17.497
Return on Equity (%)	-136.348	-82.063	-38.024	-54.267	-119.387	-174.553	-215.767	488.89
Return on Invested Capital (%)	-138.921	-86.914	-46.002	-55.936	-65.487	-137.82	-133.044	-167.114
Operating Margin (%)	-8843.453	-43.214	-82.759	-85.459	-126.846	-123.095	-26.273	-23.58
Net Profit Margin (%)	-8843.453	-43.214	-69.118	-83.48	-129.85	-132.429	-31.634	-26.68
Book Value Per Share	1.764	2.506	2.162	0.399	0.327	-0.49	-0.64	-0.667
Earnings Per Share	-3.515	-1.615	-1.228	-2.298	-2.59	-1.598	-0.503	-0.276
Cash Per Share	4.851	1.473	0.895	1.212	1.544	0.846	0.492	0.228
Working Capital Per Share	4.714	4.495	1.733	0.833	1.245	0.088	0.327	0.097
Operating Profit Per Share	0.04	3.738	1.724	1.858	0.989	0.555	1.335	0.839
EBIT Per Share	-3.515	-1.615	-1.471	-2.353	-2.59	-1.598	-0.503	-0.276
EBITDA Per Share	-3.515	-1.615	-1.471	-2.353	-2.59	-1.598	-0.503	-0.276
Free Cash Flow Per Share	-3.454	-1.594	-1.235	-2.561	-2.815	-1.812	-0.707	-0.475

Liquidity Ratios

Year End 31 December 2023	2016	2017	2018	2019	2020	2021	2022	2023
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Shares Outstanding	38.62M	47.61M	116.89M	121.68M	148.07M	177M	N/A	N/A

Key Stats and Ratios

Year End 31 December 2023	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024
	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)	USD (US$)
Shares Outstanding	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Assets (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Equity (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Return on Invested Capital (%)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin (%)	N/A	-61.445	N/A	N/A	N/A	-47.496	N/A	N/A
Net Profit Margin (%)	N/A	-65.335	N/A	N/A	N/A	-55.157	N/A	N/A
Sales Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Book Value Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Earnings Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Cash Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Profit Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBIT Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EBITDA Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Free Cash Flow Per Share	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Quick Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Inventory Turnover (Days)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Key Stats and Ratios

Market Cap	390.54M
Price to Earnings Ratio	-7.69
Price to Sales Ratio	2.05
Price to Cash Ratio	9.3
Price to Book Ratio	-13.05
Dividend Yield	-

Share Statistics

Shares Outstanding	218.18M
Average Volume (1 week)	1.84M
Average Volume (1 Month)	2.11M
52 Week Change	56.65%
52 Week High	2.48
52 Week Low	0.80

More Ratios Coming Soon!

Akebia Therapeutics

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions